WallStreetZenWallStreetZen

NASDAQ: ARQT
Arcutis Biotherapeutics Inc Stock Ownership - Who owns Arcutis Biotherapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Arcutis Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Patrick BurnettReporting Persons Title Executive Vice President and Chief Medical Officer2025-07-145,750$15.07
$86.65kSell
Patrick BurnettReporting Persons Title Executive Vice President and Chief Medical Officer2025-07-1023,000$15.05
$346.06kSell
Howard G. WelgusDirector2025-07-019,208$13.84
$127.43kSell
Howard G. WelgusDirector2025-06-1810,139$13.37
$135.57kSell
Patrick J. HeronDirector2025-06-132,646$13.08
$34.61kBuy
Patrick J. HeronDirector2025-06-05378$13.41
$5.07kBuy
Patrick J. HeronDirector2025-06-041,890$13.32
$25.18kBuy
Masaru MatsudaReporting Persons title SVP General Counsel and Corporate Secretary2025-05-281,800$13.78
$24.81kSell
Patrick J. HeronDirector2025-05-222,520$13.65
$34.40kBuy
Patrick J. HeronDirector2025-05-212,520$13.66
$34.42kBuy

1 of 7

ARQT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ARQT insiders and whales buy or sell their stock.

ARQT Shareholders

What type of owners hold Arcutis Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Patrick J. Heron16.30%19,430,454$291.65MInsider
Suvretta Capital Management LLC9.58%11,422,978$171.46MInstitution
Jennison Associates LLC9.53%11,360,875$170.53MInstitution
Rubric Capital Management LP9.20%10,966,672$164.61MInstitution
Blackrock Inc7.46%8,892,337$133.47MInstitution
Frazier Life Sciences VIII LP7.41%8,838,534$132.67MInsider
Frazier Life Sciences Management LP7.37%8,785,284$131.87MInstitution
Vanguard Group Inc5.72%6,818,078$102.34MInstitution
Polar Capital Holdings PLC5.63%6,706,475$100.66MInstitution
State Street Corp3.75%4,474,203$67.16MInstitution

1 of 3

ARQT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARQT76.98%23.02%Net SellingNet Selling
SRPT75.10%24.90%Net BuyingNet Buying
BCRX82.41%17.59%Net SellingNet Buying
FOLD65.78%34.22%Net Selling
CGON88.05%11.95%Net SellingNet Buying
View Top Biotech Stocks

Arcutis Biotherapeutics Stock Ownership FAQ

Who owns Arcutis Biotherapeutics?

Arcutis Biotherapeutics (NASDAQ: ARQT) is owned by 104.88% institutional shareholders, 31.36% Arcutis Biotherapeutics insiders, and 0.00% retail investors. Patrick J. Heron is the largest individual Arcutis Biotherapeutics shareholder, owning 19.43M shares representing 16.30% of the company. Patrick J. Heron's Arcutis Biotherapeutics shares are currently valued at $308.94M.

If you're new to stock investing, here's how to buy Arcutis Biotherapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.